XML 25 R15.htm IDEA: XBRL DOCUMENT v3.7.0.1
Stock-Based Compensation
9 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation
Stock-Based Compensation
STOCK OPTION PLANS
The number of shares authorized for issuance under the Company’s 2005 Stock Incentive Plan, as amended and restated (the “2005 Plan”), is 15,252 shares at March 31, 2017. The 2005 Plan provides for the grant of non-qualified and incentive stock options, restricted stock, stock appreciation rights and deferred stock awards to employees and non-employees. All stock options are granted with an exercise price of not less than 100% of the fair value of the Company’s common stock at the date of grant and the options generally have a term of seven years. There were 2,823 shares available for future grant under the 2005 Plan at March 31, 2017.
As part of the Company's ongoing annual equity grant program for employees, the Company grants performance-based restricted stock awards to certain executives pursuant to the 2005 Plan. Performance awards vest based on the requisite service period subject to the achievement of specific financial performance targets. Based on the performance targets, some of these awards require graded vesting which results in more rapid expense recognition compared to traditional time-based vesting over the same vesting period. The Company monitors the probability of achieving the performance targets on a quarterly basis and may adjust periodic stock compensation expense accordingly.
EMPLOYEE STOCK PURCHASE PLAN
The number of shares authorized for issuance under the Company’s 1997 Employee Stock Purchase Plan, as amended and restated (“ESPP”), is 1,800 shares. Under the ESPP, rights are granted to purchase shares of common stock at 85% of the lesser of the market value of such shares at either the beginning or the end of each six-month offering period. The ESPP permits employees to purchase common stock through payroll deductions, which may not exceed 10% of an employee’s compensation as defined in the ESPP. There were 50 and 46 shares issued under the ESPP during the nine months ended March 31, 2017 and 2016, respectively. Shares available for future purchase under the ESPP totaled 348 at March 31, 2017.
STOCK OPTION AND AWARD ACTIVITY
The following table summarizes activity of the Company’s stock option plans since June 30, 2016:
 
 
Options Outstanding
 
 
Number of
Shares
 
Weighted Average
Exercise Price
 
Weighted Average
Remaining
Contractual Term
(Years)
Outstanding at June 30, 2016
 
258

 
$
13.34

 
1.06
Granted
 

 

 
 
Exercised
 
(138
)
 
13.34

 
 
Canceled
 

 

 
 
Outstanding at March 31, 2017
 
120

 
$
13.34

 
0.56

The following table summarizes the status of the Company’s non-vested restricted stock awards since June 30, 2016:
 
 
Non-vested Restricted Stock Awards
 
 
Number of
Shares
 
Weighted Average
Grant Date
Fair Value
Outstanding at June 30, 2016
 
1,666

 
$
13.09

Granted
 
686

 
24.15

Vested
 
(711
)
 
11.46

Forfeited
 
(49
)
 
14.83

Outstanding at March 31, 2017
 
1,592

 
$
18.54


STOCK-BASED COMPENSATION EXPENSE
The Company recognized the full expense of its share-based payment plans in the consolidated statements of operations for the nine months ended March 31, 2017 and 2016 in accordance with FASB ASC 718, Compensation - Stock Compensation. The Company had $177 and $114 of capitalized stock-based compensation expense on the Consolidated Balance Sheets as of March 31, 2017 and 2016, respectively. Under the fair value recognition provisions of FASB ASC 718, stock-based compensation cost is measured at the grant date based on the value of the award and is recognized as expense over the service period, net of estimated forfeitures. The following table presents share-based compensation expenses included in the Company’s consolidated statements of operations:
 
Three Months Ended March 31,
 
Nine Months Ended March 31,
 
2017
 
2016
 
2017
 
2016
Cost of revenues
$
150

 
$
152

 
$
373

 
$
307

Selling, general and administrative
3,270

 
1,802

 
9,848

 
5,993

Research and development
295

 
196

 
1,219

 
944

Share-based compensation expense before tax
3,715

 
2,150

 
11,440

 
7,244

Income taxes
(1,418
)
 
(805
)
 
(4,381
)
 
(2,838
)
Share-based compensation expense, net of income taxes
$
2,297

 
$
1,345

 
$
7,059

 
$
4,406